Corporate Advisory

Refinancing for a listed company in the pharmaceutical sector

TicWorks analysed the company's credit quality and pricing ahead of refinancing existing shareholder loans into SEK 125 million of external debt. The project resulted in halved interest rates and an improved capital structure with no shareholder loans

Sektor
Pharmaceutical sector
Uppdragstyp
Refinancing
Storlek/Omfattning
125 MSEK
Resultat
Interest costs cut in half
Omslagsbild
"Shareholder loans at this cost are needlessly expensive for a company with this credit profile. We created competition for the financing, and the result spoke for itself — interest rates halved and a cleaner capital structure"
Roger Håkanson
Founder & CEO

Need to review your capital structure?

We analyse your existing financing and identify whether there's room to improve the terms and simplify your balance sheet